Johnson & Johnson Smashes Quarterly Sales Record with 6.6% YoY Growth

Johnson & Johnson (JNJ) has reported record quarterly results, with sales of $25.3 billion reflecting a new high for the company.

The firm's shares have delivered a significant gain in 2026 so far, up over 25%, and outperformed the S&P 500.

The company has increased its current fiscal year sales and adjusted EPS guidance, with JNJ now on track to meet its 2026 target of more than $100 billion in annual revenue for the first time in its history.

Johnson & Johnson is a Dividend Aristocrat, with a consistent history of boosting its payout, reflecting its commitment to rewarding shareholders.